Sonova (SONVY) Upgraded to “Hold” at Zacks Investment Research
Zacks Investment Research upgraded shares of Sonova (OTCMKTS:SONVY) from a strong sell rating to a hold rating in a report issued on Friday morning.
According to Zacks, “Sonova Holding AG is a manufacturer of hearing care solutions. The company’s operating business brands consists of Phonak, Unitron, Advanced Bionics and AudioNova. Its product portfolio consists of hearing instruments and cochlear implants to wireless communication solutions. Sonova Holding AG is headquartered in Stäfa, Switzerland. “
Shares of Sonova (OTCMKTS:SONVY) opened at $31.51 on Friday. Sonova has a 52 week low of $24.89 and a 52 week high of $36.19. The company has a current ratio of 1.84, a quick ratio of 1.39 and a debt-to-equity ratio of 0.35.
Sonova Holding AG designs, develops, manufactures, and distributes hearing systems for adults and children with hearing impairment. It offers hearing instruments, cochlear implants, wireless communication products, and rechargeable hearing aids, as well as professional audiological services. The company provides hearing instruments under the Phonak, Unitron, and Hansaton brand names; cochlear implants under the Advanced Bionics brand name; and professional audiological services under the Connect Hearing brand name.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.